NOVATO, Calif., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share. The net proceeds to the Company from this offering are expected to be approximately $37,250,000, after deduction of underwriting discounts and other estimated offering expenses payable by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock to cover over-allotments, if any. The offering is expected to close on or about September 13, 2011, subject to the satisfaction of customary closing conditions.
